Evidence map›Paper›PMID 40276551›Full record

ArticleFrontiers in endocrinology2025

Use of telephone calls to manage glycemic control at Mexico's northern border.

Víctor Hugo Vázquez Martínez, Humberto Martínez Bautista, Jesús Loera Morales, Francisco Daniel Garzón Garcia, David Vélez Maldonado, Patricia Muñoz Villegas

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Víctor Hugo Vázquez Martínez *Instituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 33 de Reynosa, Reynosa, Tamaulipas, Mexico.
Humberto Martínez Bautista *Centro de Investigación en Matemáticas, A.C. (CIMAT), Unidad Aguascalientes, Aguascalientes, Aguascalientes, Mexico.
Jesús Loera MoralesInstituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 33 de Reynosa, Reynosa, Tamaulipas, Mexico.
Francisco Daniel Garzón GarciaInstituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 33 de Reynosa, Reynosa, Tamaulipas, Mexico.
David Vélez MaldonadoInstituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 33 de Reynosa, Reynosa, Tamaulipas, Mexico.
Patricia Muñoz VillegasCentro de Investigación en Matemáticas, A.C. (CIMAT), Unidad Aguascalientes, Aguascalientes, Aguascalientes, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Telephone calls were used for glycemic control in type 2 diabetes mellitus (T2DM) patients during the Covid-19 pandemic. The study's objective was to determine the factors that favor glycemic control in patients with T2DM using telephone calls in the Mexico's northern border. Methods: A retrospective cohort study was conducted with T2DM patients from the Family Medicine Unit 33 in Reynosa, Tamaulipas, from June 2021 to June 2022. The evaluation of glycemic control involved measuring glycated hemoglobin at the beginning and end of telephone follow-up. Clinical, demographic, social, and laboratory factors were analyzed using univariate and bivariate statistical methods to compare initial and final glycemic control, finally, two logistic regression models were estimated considering glycemic control as a binary variable. Results: A total of 287 participants were followed up, comprising 122 men and 165 women, where 71.78% received nine or more phone calls. Initially, 49.13% had glycemic control, but by the end of the follow-up, it increased by 7%. Females show an Odds Ratio (OR) of 0.475 (95% CI 0.269-0.838), high-density lipid levels with an OR = 0.982 (p=0.078), and 11 follow-up telephone calls with an OR = 0.403 (95% CI 0.165-0.985), which represented factors contributing to glycemic control. Poor glycemic control is more likely in individuals with a high cardiovascular risk, with an OR of 2.193 (p=0.085). Conclusion: Cell phone calls can effectively control glycemia in T2DM patients. Therefore, they can be used as a substitute for in-person medical care.

Indexed as

COVID-19Diabetes Mellitus, Type 2Glycemic ControlTelephoneAdultAgedBlood GlucoseFemaleFollow-Up StudiesGlycated HemoglobinHumansMaleMexicoMiddle AgedRetrospective StudiesSARS-CoV-2Blood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humancardiovascular riskglycemic controltelemedicinetelephonetype 2 diabetes mellitus

Identifiers

PMID40276551
PMCPMC12018243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.